SCHEMBL211105

SCHEMBL211105

Cc1ccc(O)c(Cc2cc(C)cc(CO)c2O)c1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AMY1A P0DUB6 1/20 0.86
HIF1A Q16665 4/20 0.49
CYP2C9 P11712 3/20 0.49
CYP2C19 P33261 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.47
HSPA5 P11021 2/20 0.44
TRPA1 O75762 1/20 0.42
SHBG P04278 1/20 0.42
ALOX15 P16050 4/20 0.41
LMNA P02545 3/20 0.41
HPGD P15428 3/20 0.41
HTT P42858 2/20 0.41
MEN1 O00255 2/20 0.41
MAPT P10636 2/20 0.41
ALOX12 P18054 2/20 0.41
KMT2A Q03164 2/20 0.41
SLC22A1 O15245 1/20 0.41
USP2 O75604 1/20 0.41
HSP90AA1 P07900 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29623092 0.93 AMY1A (1.00) AMY1AHIF1ACYP2C9CYP2C19SMN1; SMN2
SCHEMBL30320292 0.93 AMY1A (1.00) AMY1AHIF1ACYP2C9CYP2C19SMN1; SMN2
SCHEMBL1345563 0.93 AMY1A (1.00) AMY1AHIF1ACYP2C9CYP2C19SMN1; SMN2
SCHEMBL1345514 0.93 AMY1A (1.00) AMY1AHIF1ACYP2C9CYP2C19SMN1; SMN2
SCHEMBL218957 0.93 AMY1A (1.00) AMY1AHIF1ACYP2C9CYP2C19SMN1; SMN2
SCHEMBL1345917 0.93 AMY1A (1.00) AMY1AHIF1ACYP2C9CYP2C19SMN1; SMN2
SCHEMBL3820165 0.93 AMY1A (1.00) AMY1AHIF1ACYP2C9CYP2C19SMN1; SMN2
SCHEMBL18352 0.93 AMY1A (1.00) AMY1AHIF1ACYP2C9CYP2C19SMN1; SMN2
Phosphine SCHEMBL26919025 0.91 AMY1A (0.96) AMY1AHIF1ACYP2C9CYP2C19SMN1; SMN2
Formaldehyde SCHEMBL28912209 0.87 AMY1A (0.89) AMY1AHIF1ACYP2C9CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106232655-B Formaldehyde-free phenolic resin, downstream product, synthesis and application thereof 西安大略大学 2020-09-11 CN disclosed
CN-106232655-A Formaldehydeless phenolic resin, downstream product and synthesis thereof and purposes 西安大略大学 2016-12-14 CN disclosed
US-RE43067-E1 Method for producing new polynuclear poly(formylphenol) HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2012-01-03 US disclosed
US-7750190-B2 reacting hexamethylene tetramine in presence of acid; industrial scale; photoresists HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2010-07-06 US disclosed
US-20090182175-A1 METHOD FOR PRODUCING NEW POLYNUCLEAR POLY(FORMYLPHENOL) HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090182175-A1 METHOD FOR PRODUCING NEW POLYNUCLEAR POLY(FORMYLPHENOL) PCBP1, FPR2, PNKP AMY1A 2459/4885HIF1A 4412/4885CYP2C9 2247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.